Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bucher

Showing results (331-340 of 406) with videos related to

Pageof 41
Sort By:
Evidence-Based Child Health : a Cochrane Review Journal|July 24, 2013
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Beat Müller, Mirjam Christ-Crain, et al.
AIDS (London, England)|October 13, 2023
Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1Frédérique Chammartin, Alexandra Griessbach, Katharina Kusejko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2012
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysisPhilipp Schuetz, Matthias Briel, Mirjam Christ-Crain, et al.
Annals of Internal Medicine|March 15, 2021
Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort StudyFrédérique Chammartin, Sara Lodi, Roger Logan, et al.
The Cochrane Database of Systematic Reviews|September 14, 2012
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Beat Müller, Mirjam Christ-Crain, et al.
Critical Care (London, England)|April 19, 2015
Prognostic value of procalcitonin in respiratory tract infections across clinical settingsAlexander Kutz, Matthias Briel, Mirjam Christ-Crain, et al.
Journal of Translational Medicine|January 25, 2011
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort StudyJan Fehr, Tracy R Glass, Séverine Louvel, et al.
Journal of Market Access & Health Policy|July 29, 2024
The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access AcademyElaine Julian, Oriol Solà-Morales, Maria João Garcia, et al.
Antiviral Therapy|February 7, 2009
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studiesRoss J Harris, Jonathan A C Sterne, Sophie Abgrall, et al.
Annals of Internal Medicine|October 18, 2016
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort StudyQing Wang, Andrea De Luca, Colette Smith, et al.
Pageof 41

Showing results (331-340 of 406) with videos related to

Sort By:
Pageof 41
Evidence-Based Child Health : a Cochrane Review Journal|July 24, 2013
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Beat Müller, Mirjam Christ-Crain, et al.
AIDS (London, England)|October 13, 2023
Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1Frédérique Chammartin, Alexandra Griessbach, Katharina Kusejko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2012
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysisPhilipp Schuetz, Matthias Briel, Mirjam Christ-Crain, et al.
Annals of Internal Medicine|March 15, 2021
Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort StudyFrédérique Chammartin, Sara Lodi, Roger Logan, et al.
The Cochrane Database of Systematic Reviews|September 14, 2012
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Beat Müller, Mirjam Christ-Crain, et al.
Critical Care (London, England)|April 19, 2015
Prognostic value of procalcitonin in respiratory tract infections across clinical settingsAlexander Kutz, Matthias Briel, Mirjam Christ-Crain, et al.
Journal of Translational Medicine|January 25, 2011
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort StudyJan Fehr, Tracy R Glass, Séverine Louvel, et al.
Journal of Market Access & Health Policy|July 29, 2024
The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access AcademyElaine Julian, Oriol Solà-Morales, Maria João Garcia, et al.
Antiviral Therapy|February 7, 2009
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studiesRoss J Harris, Jonathan A C Sterne, Sophie Abgrall, et al.
Annals of Internal Medicine|October 18, 2016
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort StudyQing Wang, Andrea De Luca, Colette Smith, et al.
Pageof 41